MD Anderson Cancer Center at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
MD Anderson Cancer Center brings 26 presentations to IDWeek 2026 in Washington. Its program centres on infections in people with cancer, including catheter-related bloodstream infections, invasive aspergillosis and viral complications of newer cancer therapies. Distinctive work tracks hepatitis B reactivation during bispecific T-cell engager therapy and links Klebsiella capsule type to phage susceptibility.
| Organization | IDWeek 2026 Attendance |
|---|---|
MD Anderson Cancer Center Houston, TX | |
Session Wed Oct 21 1:30pm–3:15pm Global Elimination of Hepatitis C in 2026 HIV, sexually transmitted infections and viral hepatitisGlobal and public health Talk Thu Oct 22 11:30am–11:42am D-PLEX100 Lowers the Microbial Burden Without Selecting for Multidrug-Resistant Bacteria: Pooled Microbiology from Three Randomized Trials (N=2,185) Infection prevention and healthcare epidemiologyAntimicrobials, resistance and stewardship Poster Thu Oct 22 12:15pm–1:30pm Antibiotic Lock Therapy and Early Catheter Removal Deliver Comparable Outcomes in Catheter-Related Bloodstream Infections Among Cancer Patients With Long-Term Central Venous Catheters (LT CVC) Poster Thu Oct 22 12:15pm–1:30pm Linking Capsule Type with Bacteriophage Susceptibility in Multinational Genomically Diverse Klebsiella pneumoniae Poster Thu Oct 22 12:15pm–1:30pm Reduced Antimicrobial Susceptibility in Polymicrobial versus Monomicrobial Biofilms Using a Three-Dimensional Wound Biofilm Model Poster Thu Oct 22 12:15pm–1:30pm Shifting Microbial Epidemiology of Catheter-Related Bloodstream Infections: A 25-Year, Multi-Cohort Study in Cancer Patients with Long-Term Central Venous Catheters Poster Thu Oct 22 12:15pm–1:30pm The Role of Cytomegalovirus Cell Mediated Immunity Testing Before and After Chimeric Antigen Receptor Therapy Session Thu Oct 22 1:45pm–3:00pm Session Thu Oct 22 1:45pm–3:00pm Session Thu Oct 22 1:45pm–3:00pm Hepatitis B: From Prevention to Functional Cure Infection prevention and healthcare epidemiologyGlobal and public healthHIV, sexually transmitted infections and viral hepatitis Talk Thu Oct 22 1:45pm–2:10pm Session Fri Oct 23 8:00am–9:00am Expanding the Diagnostic Toolkit for Viral Hepatitis and Managing Unique Infected Populations HIV, sexually transmitted infections and viral hepatitisDiagnostics and diagnostic stewardship Session Fri Oct 23 11:30am–11:55am Poster Fri Oct 23 12:15pm–1:30pm Current Gaps Between Perceived Value and Utilization of Teaching and Learning Resources in Transplant–Oncology Infectious Diseases at a Comprehensive Cancer Center: Navigation and Workflow Barriers Poster Sat Oct 24 12:15pm–1:30pm Central Nervous System Involvement in Disseminated Aspergillosis Among Cancer Patients: A 30-Year Institutional Cohort of Clinical Features, Management, and Outcomes Poster Sat Oct 24 12:15pm–1:30pm Clinical Outcomes of Respiratory Viral Infections in Recipients of Cellular Therapy Over two Seasons Poster Sat Oct 24 12:15pm–1:30pm Emerging Opportunist or Clinical Harbinger? A Review of Candida kefyr Cases in Cancer Patients Poster Sat Oct 24 12:15pm–1:30pm Hepatitis B Virus Reactivation in Patients with Cancer Receiving Bispecific T-cell Engager Therapy Poster Sat Oct 24 12:15pm–1:30pm Improving Influenza Vaccination Assessment and Documentation among High-Risk Cancer Patients: Evolution of a Longitudinal Quality Improvement Initiative Poster Sat Oct 24 12:15pm–1:30pm Microbiologic Profile and Treatment Outcomes in Temporal Bone Osteoradionecrosis: A 23-Year Single-Center Experience Poster Sat Oct 24 12:15pm–1:30pm Outcomes of Parainfluenza Virus Infections in Hospitalized Adult Patients: A Two-Center Study From 2 Different Continents Poster Sat Oct 24 12:15pm–1:30pm Primary Liposomal Amphotericin B Monotherapy versus Combination with Azoles or Echinocandins for Invasive Aspergillosis in Hematologic Malignancies: Comparable Outcomes Over 22 Years in a Large Single-Center Cohort Poster Sat Oct 24 12:15pm–1:30pm Transcriptional regulation of 42 candidate genes as predictors of severe respiratory viral infections in hematopoietic cell transplant recipients – a prospective cohort study Talk Sat Oct 24 1:45pm–2:10pm Overview of Recently Developed Antineoplastic Agents and Viral Complications Transplant and immunocompromised hosts Session Sat Oct 24 1:45pm–3:00pm Viral Infections With Novel Antineoplastic Treatments Transplant and immunocompromised hosts Session Sat Oct 24 3:15pm–4:30pm Not Just Managing but Vanquishing: The New Era of Hepatitis Antivirals HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship |
Instantly find 20 buyers from MD Anderson Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction